Mico-QT TARGET Dermatological Serum
Mico-QT TARGET is our new dermatological body serum of Reishi and Cordyceps extracts with argan oil and urea, indicated for the care, prevention and early management of skin alterations associated with skin toxicity induced by chemotherapeutic treatments.
MICO-QT TARGET is our new dermatological body serum of Reishi and Cordyceps extracts with argan oil and urea, indicated for the care, prevention and early management of skin alterations associated with skin toxicity induced by chemotherapeutic treatments.
At Hifas da Terra we are committed to a new way of understanding health that places the patient at the center of attention, understanding their specific needs and applying knowledge of the natural world, to develop a range of specific cosmeceuticals aimed at preventing and controlling lesions caused in the skin by oncological treatments, especially some types of chemotherapy and the new anti-diana drugs, which helps to favor therapeutic compliance.
The efficacy of this novel organic cream is based on the synergy of its active ingredients, extracts of medicinal mushrooms Ganoderma lucidum and Cordyceps sinensis on a base of argan oil (Arginia spinosa) and sacha inchi oil (Plukenetia volubilis), sodium hyaluronate, vitamins and aloe vera (Aloe barbadensis) that modulate cellular activity, minimize skin oxidation and help relieve redness, dryness, desquamation and hyperpigmentation, thus promoting healing and protecting against radiation.
MICO-QT Target contains urea, a component that has been shown in randomized clinical trials to be effective in preventing dermatological toxicity.
Mico-QT Target is formulated with extracts of two medicinal mushrooms of high therapeutic interest: Ganoderma lucidum and Cordyceps sinensis. For their extraction we apply the latest technologies, which implies the regular fractionation of their bioactive compounds.
Ganoderma lucidum and Cordyceps sinensis extracts are rich in a multitude of bioactive compounds including β-glucans, natural antioxidants, B vitamins, essential amino acids, trace elements and minerals (Fe, Se, Zn).
Hyphae da Terra has developed Mico-QT Target, a formulation that has demonstrated antioxidant capacity of the two mushroom extracts present: 8.04 ± 0.10 g Trolox*/100 g equivalent ─Ganoderma lucidum─ and of 3.47 ± 0.16 g Trolox*/100 g equivalent -Cordyceps sinensis─.
*Standard used in assays to determine antioxidant capacity.
In experiences carried out at Hifas da Terra, the fungal extracts included in Mico-QT Target have shown antibacterial capacity against several strains of clinical interest, and recent studies have also shown the healing capacity of these extracts.
Directions for use
Cleanse the skin thoroughly with Mico-Soap ONCO (Reishi, calendula &amp lemon). Apply directly with water or with the help of a cotton pad with special emphasis on the affected area. Dry gently.
Apply MICO-QT TARGET in sufficient quantity with a gentle massage on the affected areas. It is possible to repeat applications whenever necessary, even several times a day.
For external use only. Avoid direct contact with eyes, lips, nostrils and mucous membranes. In case of accidental contact, remove the cream with plenty of water. Keep out of the reach of children.
The extracts of Reishi (Ganoderma lucidum) and Cordyceps (Cordyceps sinensis) are of special interest for the prevention and treatment of the skin against external aggressions thanks to their anti-inflammatory, healing and antioxidant power.
Cordyceps (Cordyceps sinensis): the extract of this fungus promotes oxygenation and increased intracellular energy. It has also demonstrated anti-inflammatory activity and protection against radiation. It also reduces signs of fatigue, soothes itching and pruritus and prevents desquamation, thus allowing skin tone to be restored.
Reishi (Ganoderma lucidum) and Cordyceps (Cordyceps sinensis) act at the cellular level. In addition, it has demonstrated anti-peroxidative and anti-inflammatory activity, protecting proteins from oxidation. The skin retains its elasticity and firmness, preventing dryness and flaking.
Hydroxyethyl urea 10%: it has proven its efficacy in randomized clinical trials to prevent dermatological toxicity of anti-diana and chemotherapeutic agents.
Urea is known to improve stratum corneum hydration. However, topical use of urea shows improved epidermal barrier function and possible antimicrobial activity. Urea has a very low toxicity profile, hence its potential in cutaneous use.
Following excretion of cytotoxic drugs via the exocrine sweat glands, urea has a very low toxicity profile, hence its potential for skin use.